newsfilter
← Latest News
GlobeNewswire·

Akari Therapeutics Announces Release of the Next CEO Corner Segment

Access the Akari CEO Corner here BOSTON and LONDON, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (NASDAQ:AKTX), an oncology biotechnology company developing novel payloads for antibody drug conjugates